"We plan to double our copper production by the end of the decade. There remains significant upside potential in the gold industry, and the copper operations are strategic and additive to that."
DIRECTOR OF INNOVATION AND BUSINESS DEVELOPMENT, PROCOS SPA
"We are currently building a new workshop in which we are specifically going to add small-scale lines to support clinical trial supply and generic product manufacturing."
"We used our voice to educate on the value of medical innovation and boasted the strength of New Jersey’s vibrant ecosystem, which was responsible for more than 50% of all novel FDA approvals in 2023."